Surgery Doctors in Clayton, NM Accepting Medicare
2 Surgery doctors found. Showing 1 - 2
 Paul Michael Willette, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 300 Wilson St, Clayton, NM 88415 Phone: 575-374-0021 |
Patrick J C De Baca, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 315 N 3rd Ave, Clayton, NM 88415 Phone: 575-374-2273 Fax: 575-374-2498 |
News Archive
Abnormal levels of lysophosphatidic acid can trigger congenital hydrocephalus
Scientists at The Scripps Research Institute have found what may be a major cause of congenital hydrocephalus, one of the most common neurological disorders of childhood that produces mental debilitation and sometimes death in premature and newborn children.
Infant feeding and the development of obesity: what does the science tell us?
On Wednesday, April 9, 2008, a symposium at the American Society for Nutrition's annual meeting at Experimental Biology was held in which noted scientists discussed new infant feeding studies that used methodology such as randomized clinical trials (involving breastfeeding promotion) as well as sibling pairs analysis.
Parental observations and perceptions important in detecting sleep problems in children
A new study from the University of Rochester has found that parental observations and perceptions of their childrens' sleep habits are a valuable supplement to objective laboratory tests in detecting obstructive sleep apnea (OSA).
Study provides preliminary evidence that Parkinson's disease may start in the gut
Parkinson's disease may start in the gut and spread to the brain via the vagus nerve, according to a study published in the April 26, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The vagus nerve extends from the brainstem to the abdomen and controls unconscious body processes like heart rate and food digestion.
Presence of circulating tumor cells in early-stage breast cancer doubles risk of relapse and death
The presence of one to four circulating tumor cells (CTCs) in the blood of early-stage breast cancer patients almost doubled patient's risk of cancer relapse and death, and five or more CTCs increased recurrence by 400 percent and death by 300 percent, according to Phase III results of the SUCCESS trial. These cells were found in patients after surgery but before chemotherapy treatment.
› Verified 2 days ago